New graft manipulation strategies improve the outcome of mismatched stem cell transplantation in children with primary immunodeficiencies

J Allergy Clin Immunol. 2019 Jul;144(1):280-293. doi: 10.1016/j.jaci.2019.01.030. Epub 2019 Feb 4.

Abstract

Background: Mismatched stem cell transplantation is associated with a high risk of graft loss, graft-versus-host disease (GvHD), and transplant-related mortality. Alternative graft manipulation strategies have been used over the last 11 years to reduce these risks.

Objective: We investigated the outcome of using different graft manipulation strategies among children with primary immunodeficiencies.

Methods: Between 2006 and 2017, 147 patients with primary immunodeficiencies received 155 mismatched grafts: 30 T-cell receptor (TCR) αβ/CD19-depleted grafts, 43 cord blood (CB) grafts (72% with no serotherapy), 17 CD34+ selection with T-cell add-back grafts, and 65 unmanipulated grafts.

Results: The estimated 8-year survival of the entire cohort was 79%, transplant-related mortality was 21.7%, and the graft failure rate was 6.7%. Posttransplantation viral reactivation, grade II to IV acute graft-versus-host disease (aGvHD), and chronic graft-versus-host disease (cGvHD) complicated 49.6%, 35%, and 15% of transplantations, respectively. Use of TCRαβ/CD19 depletion was associated with a significantly lower incidence of grade II to IV aGvHD (11.5%) and cGvHD (0%), although with a greater incidence of viral reactivation (70%) in comparison with other grafts. T-cell immune reconstitution was robust among CB transplants, although with a high incidence (56.7%) of grade II to IV aGvHD. Stable full donor engraftment was significantly greater at 80% among TCRαβ+/CD19+-depleted and CB transplants versus 40% to 60% among the other groups.

Conclusions: Rapidly accessible CB and haploidentical grafts are suitable alternatives for patients with no HLA-matched donor. Cord transplantation without serotherapy and TCRαβ+/CD19+-depleted grafts produced comparable survival rates of around 80%, although with a high rate of aGvHD with the former and a high risk of viral reactivation with the latter that need to be addressed.

Keywords: Mismatched stem cell transplantation; T-cell receptor αβ/CD19; cord; graft-versus-host disease; immune reconstitution.

MeSH terms

  • Adolescent
  • Antigens, CD19 / immunology
  • Child
  • Child, Preschool
  • Graft vs Host Disease / etiology
  • Graft vs Host Disease / immunology
  • Humans
  • Infant
  • Primary Immunodeficiency Diseases / immunology
  • Primary Immunodeficiency Diseases / therapy*
  • Receptors, Antigen, T-Cell, alpha-beta / immunology
  • Stem Cell Transplantation / adverse effects
  • Stem Cell Transplantation / methods*
  • Virus Diseases / etiology
  • Virus Diseases / immunology

Substances

  • Antigens, CD19
  • CD19 molecule, human
  • Receptors, Antigen, T-Cell, alpha-beta